Regulations.gov document
Watson Laboratories, Inc.; Proposal To Withdraw Approval of an Abbreviated New Drug…
Notice · FDA-2019-N-3723 · posted Oct 28, 2019
Key facts
| Document ID | FDA-2019-N-3723-0001 |
|---|---|
| Title | Watson Laboratories, Inc.; Proposal To Withdraw Approval of an Abbreviated New Drug Application for Oxycodone Hydrochloride and Ibuprofen Tablets; Opportunity for a Hearing |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2019-N-3723 |
| Posted | Oct 28, 2019 |
| Federal Register citation | 84 FR 57739 |
| FR document number | 2019-23490 |
| Comment period opens | Oct 28, 2019 |
| Comments due | Dec 28, 2019 |
| Effective date | Oct 28, 2019 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: